151 related articles for article (PubMed ID: 1672634)
1. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD.
Karpel JP
Chest; 1991 Apr; 99(4):871-6. PubMed ID: 1672634
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD.
Karpel JP; Pesin J; Greenberg D; Gentry E
Chest; 1990 Oct; 98(4):835-9. PubMed ID: 2145136
[TBL] [Abstract][Full Text] [Related]
3. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
Friedman M
Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
[TBL] [Abstract][Full Text] [Related]
4. Results of a multicenter study of nebulized inhalant bronchodilator solutions.
Tashkin DP; Bleecker E; Braun S; Campbell S; DeGraff AC; Hudgel DW; Boyars MC; Sahn S
Am J Med; 1996 Jan; 100(1A):62S-69. PubMed ID: 8610720
[TBL] [Abstract][Full Text] [Related]
5. Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD.
LeDoux EJ; Morris JF; Temple WP; Duncan C
Chest; 1989 May; 95(5):1013-6. PubMed ID: 2523291
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.
Tashkin DP; Ashutosh K; Bleecker ER; Britt EJ; Cugell DW; Cummiskey JM; DeLorenzo L; Gilman MJ; Gross GN; Gross NJ
Am J Med; 1986 Nov; 81(5A):81-90. PubMed ID: 2947465
[TBL] [Abstract][Full Text] [Related]
7. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF.
Weintraub SJ; Eschenbacher WL
Chest; 1989 Apr; 95(4):861-4. PubMed ID: 2522385
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the effects of anticholinergic and beta 2-agonist and combination therapy on respiratory impedance in COPD.
Wesseling G; Mostert R; Wouters EF
Chest; 1992 Jan; 101(1):166-73. PubMed ID: 1530836
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
Pillet O; Manier G; Castaing Y
Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
[TBL] [Abstract][Full Text] [Related]
10. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
Colice GL
Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
[TBL] [Abstract][Full Text] [Related]
11. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease.
Maguire GP; Newman T; DeLorenzo LJ; Brown RB; Stone D
Chest; 1991 Nov; 100(5):1300-5. PubMed ID: 1935285
[TBL] [Abstract][Full Text] [Related]
13. Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?
Blosser SA; Maxwell SL; Reeves-Hoche MK; Localio AR; Zwillich CW
Chest; 1995 Sep; 108(3):730-5. PubMed ID: 7656624
[TBL] [Abstract][Full Text] [Related]
14. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
Nishimura K; Koyama H; Ikeda A; Sugiura N; Kawakatsu K; Izumi T
Chest; 1995 Mar; 107(3):718-23. PubMed ID: 7874943
[TBL] [Abstract][Full Text] [Related]
15. Aging does not affect beta-agonist responsiveness after methacholine-induced bronchoconstriction.
Parker AL
J Am Geriatr Soc; 2004 Mar; 52(3):388-92. PubMed ID: 14962153
[TBL] [Abstract][Full Text] [Related]
16. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
Newnham DM; Dhillon DP; Winter JH; Jackson CM; Clark RA; Lipworth BJ
Thorax; 1993 Nov; 48(11):1151-5. PubMed ID: 8296260
[TBL] [Abstract][Full Text] [Related]
17. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.
Rennard SI; Serby CW; Ghafouri M; Johnson PA; Friedman M
Chest; 1996 Jul; 110(1):62-70. PubMed ID: 8681667
[TBL] [Abstract][Full Text] [Related]
18. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
19. Bronchodilator therapy in chronic airflow obstruction.
Niewoehner DE; Leatherman JW
Chest; 1984 Aug; 86(2):161-2. PubMed ID: 6146498
[No Abstract] [Full Text] [Related]
20. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
